MINOXIDIL 5%
MINOXIDIL 5%
Single-compound, solvent-based topical research formulation developed for localized, non-clinical androgen receptor interaction studies.
Prefer email communication?
Request this formulation via our consultation form.
Request-only supply. No instant checkout. All formulation requests are reviewed before fulfilment.
Technical Data
Chemical Identification
Physicochemical Characteristics
Documentation & Analytical Data
Research Documentation
Formulation Specification
Concentration system: 5% w/v
Equivalent concentration: 50 mg/mL
Total active content: 2.5 g per 50 mL
Vehicle system: Ethanol 96% (Ph. Eur.) / Propylene Glycol (Ph. Eur.) / Diethylene Glycol Monoethyl Ether — Transcutol® P (Ph. Eur.) / Purified Water (Ph. Eur.)
Solvent ratio: 45 / 30 / 5 / 20
Formulation architecture: Hydroalcoholic multi-solvent topical carrier system designed to support compound solubility, formulation consistency, and controlled surface application modeling.
Water content: Purified water included as part of the carrier system.
Formulation complexity: Single-compound system
Research Context
Minoxidil is a vasodilatory compound investigated within non-clinical research models involving localized topical delivery systems, follicular biology interaction models, and surface-confined formulation behavior.
In topical research contexts, Minoxidil formulations are commonly evaluated as surface-applied compounds where localized delivery behavior, carrier-system compatibility, and compound dispersion characteristics are relevant experimental parameters.
Experimental focus is generally directed toward localized formulation exposure models, topical delivery architecture, and controlled surface-level interaction behavior within non-clinical laboratory environments.
This GeneTherica formulation is positioned as a research-grade topical solution for controlled, non-clinical laboratory use. It is not supplied for therapeutic, diagnostic, cosmetic, or human application.
Storage & Handling
Storage range: 15–25°C under controlled room-temperature conditions.
Storage conditions: Store tightly closed in a cool, dry, dark environment.
Light sensitivity: Protect from direct sunlight and UV exposure.
Temperature stability: Avoid freezing and excessive heat exposure.
Air exposure: Minimize prolonged exposure to air.
Closure requirement: Keep container tightly sealed when not in use.
Stability context: Storage conditions are intended to support solvent balance, formulation consistency, and compound stability during controlled non-clinical handling.
Research Use Notice
Supplied exclusively for laboratory research and analytical applications.
Not intended for therapeutic, cosmetic, veterinary, food, household, diagnostic, or human application.
Handling should occur within qualified non-clinical research environments only.
Overview
Minoxidil is a vasodilatory compound investigated within controlled research environments involving localized topical delivery systems and follicular biology interaction models.
Within topical research frameworks, Minoxidil formulations are primarily examined for their behavior in hydroalcoholic carrier systems, compound dispersion, and surface-level application environments.
Experimental focus is generally directed toward formulation stability, solvent compatibility, localized delivery behavior, and research models related to follicular and scalp-surface interaction pathways.
Research applications focus on controlled topical carrier systems designed to support uniform compound distribution and non-clinical laboratory evaluation.
This formulation is presented as a research-grade topical solution intended exclusively for scientific, analytical, and laboratory-based use under appropriate controlled handling conditions.
